In human colon cancer cells, diminished IDO1 activity reduced nuclear and activated β-catenin, transcription of its target genes (cyclin D1 and Axin2), and, ultimately, proliferation [33, 40]. This evidence concerns the gene IDO1 and malignant colon neoplasm.